TCT 740: Transcatheter solution for a massive tricuspid regurgitation and refractory right side heart failure in a patient with a previous cardiac transplantation. Receive the the latest news, ...
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...
Lush vegetation is great for a gardener, but alarming for a cardiologist. For them, the news that Angiodynamics Inc. received U.S. FDA breakthrough device designation for its Angiovac system to remove ...
A workforce on the surgical management of tricuspid endocarditis in patients who inject drugs cautioned against relying on vegetation size and microbiology as criteria for surgery in these patients.
TCT 818: Exacerbation of aortic stenosis following transcatheter mitral valve repair - a structural change or an effect of improved hemodynamics? Receive the the latest news, research, and ...
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback